Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy

  • Alison A Murphy, Eva Herrmann, Anu O Osinusi, Lynn Wu, William Sachau, Richard A Lempicki, Jun Yang, Tei L Chung, Brad J Wood, Bart L Haagmans, Shyam Kottilil, Michael A Polis
  • AIDS, June 2011, Wolters Kluwer Health
  • DOI: 10.1097/qad.0b013e3283471d53

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Bart L. Haagmans